Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

Autor: Bokemeyer, C. *, Bondarenko, I., Hartmann, J.T., de Braud, F., Schuch, G., Zubel, A., Celik, I., Schlichting, M., Koralewski, P.
Zdroj: In Annals of Oncology July 2011 22(7):1535-1546
Databáze: ScienceDirect